Centene, Molina: Navigating Medicaid & Medicare Challenges
Former SVP of Medicare at Centene Corporation
inpractise.com/articles/centene-molina-medicaid-and-medicare-challenges-in-an-evolving-landscape
Former SVP of Medicare at Centene Corporation
Interview Transcript
This is a snippet of the transcript, sign up to read more.
For my context, I don't know much about the Medicaid program in Florida. If I recall correctly, it's not an expansion state. Who are the other competitors in the state?
Centene was number one after we combined those two companies. Humana was number two, and Simply, which is an Elevance company, is number three. After that, Molina was in the state, but they lost the last bid. I think they're operating in just one region now. Moving forward with the new contract, United lost significant membership in the last bid. The last RFP was in 2023, and all the plans were negotiating in 2024. The new award started on February 1st. Everything is quite scrambled. Centene ultimately was the primary winner along with Humana and Simply.
This is a snippet of the transcript, sign up to read more.
Related Content
BrightSpring Health Services: Challenges in Leveraging Nursing Assets
Former Executive PMO Consultant at BrightSpring
UnitedHealth: Partner Healthcare Providers' VBC Migration Challenges
Former VP Value Based Care & Network Strategy at UnitedHealthcare
UnitedHealth, Elevance, Cigna & Value-Based Care: Acquiring vs Partnerships with Healthcare Providers
Former VP - New Ventures - Value-Based Care at UnitedHealth Group
US Value-Based Healthcare: Physician Incentives
Former VP of Corporate Venture Capital at Anthem
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.